我的网站热门文章

作者：建道来源：原创发布日期：08-21

留守儿童

Indonesia bans syrup medicines as children die_我的网站

头脑风暴

一 | Jakarta, Oct 20 (UNI) The deaths of nearly 100 children in Indonesia has prompted the country to suspend sales of all syrup and liquid medication.
It comes just weeks after a cough syrup in The Gambia was linked to the deaths of nearly 70 children, reports BBC.
Indonesia said some syrup medicine was found to contain ingredients linked to acute kidney injuries (AKI), which have killed 99 young children this year.
It was not clear if the medicine were imported or locally produced.
On Thursday, Indonesian health officials said they had reported around 200 cases of AKI in children, most of who were aged under five, the BBC reported.
Earlier this month, the The World Health Organization (WHO) issued a global alert over four cough syrups that were linked to the deaths of almost 70 children in The Gambia.
The WHO found the syrups used there -- made by an Indian pharmaceutical company -- contained "unacceptable amounts" of diethylene glycol and ethylene glycol. The syrups have been "potentially linked with acute kidney injuries", said the organisation.
Indonesia's Health Minister on Thursday said the same chemical compounds were also found in some medicines used locally.
"Some syrups that were used by AKI child patients under five were proven to contain ethylene glycol and diethylene glycol that were not supposed to be there, or of very little amount," said Budi Gunadi Sadikin. He did not disclose how many cases involved the toxic medicines.
Indonesian authorities said the cough syrups used in The Gambia were not sold locally.
Indonesian authorities have so far not disclosed the brands or types of syrup medicines linked to sick children - instead just temporarily banning the sale and prescription of all syrup and liquid medicines.
UNI MR。　　8月25日，三大指数集体低开，上证指数低开0.48%，深证成指低开0.8%，创业板指低开0.84%。

二 | 板块方面，卫浴制品领涨，海鸥住工涨10.13%，钟表珠宝、饰品等开盘涨幅居前。　　个股方面，5股竞价涨停，其中深中华A4连板、海鸥住工2连板、中南文化2连板、建设机械2连板、江特电机首板。　　免责声明：本文基于AI生产，仅供参考，不构成任何投资建议，据此操作风险自担。东方财富发布此内容旨在传播更多信息，与本平台立场无关。